Evidence map

ArticleInternal medicine (Tokyo, Japan)2023

Nephroprotective Effects of Dapagliflozin in Patients with Type 2 Diabetes.

Yasuhiro Iijima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2023
2024
2025
this papertrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 36858619